Purchase Order 36C26224P0303
- Not listed
- This sole source purchase order awarded by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 21 is valued at $303,692 and provides for FDG, F18-NAF AND NEURACEQ doses for the period of February 15, 2020 through February 14, 2021. The prime contractor is Sofie Co., doing business as Sofie and operating as a subsidiary of Sofie Biosciences, Inc. The place of performance is Culver City, California. The contract has a firm fixed price and calls for...
- This is a firm fixed-price purchase order awarded by the Veterans Integrated Service Network 4 (VISN 4) of the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract, valued at $663,619.64, is for the supply of radiopharmaceuticals to support medical imaging and cancer treatment programs for veterans. Sofie is an experienced provider of specialized imaging agents, prostate cancer detection tools, and injectable cancer drugs to the VA, the Defense...
- This federal contract award was issued by the Defense Health Agency (DHA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc., for the supply of Neuraceq (florbetaben F-18), a nuclear medicine PET imaging agent used to estimate amyloid neuritic plaque density in adult patients at the Walter Reed National Military Medical Center. The $17,500.00 firm-fixed-price purchase order does not have a set-aside designation. Sofie Biosciences is a specialized manufacturer and supplier of molecular...
- This federal contract award to Sofie CO. (doing business as Sofie), a subsidiary of Sofie Biosciences, Inc., was issued by the Veterans Integrated Service Network 10 (VISN 10) of the Department of Veterans Affairs (VA). The $1,306,250.00 delivery order is to exercise Ordering Period 2 and add 64 doses of a radiopharmaceutical PET product. The contract is a firm fixed-price award, with no set-aside designation. Sofie is an experienced supplier of radiopharmaceuticals, pharmaceuticals, and related...
- This is a federal purchase order awarded by the Department of Veterans Affairs (VA) to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of the radiopharmaceutical F19, with a ceiling value of $17,535.00 and a period of performance ending on June 30, 2022. The contract has no set-aside designation. Sofie is a specialized provider of radiopharmaceuticals, pharmaceuticals, and related services to various federal agencies, including the VA,...
- This contract award to Sofie CO., doing business as Sofie, is for the supply of radiopharmaceuticals to the U.S. Department of Veterans Affairs (VA). The $171,500.00 firm fixed-price purchase order has an ultimate completion date of April 4, 2019 and was awarded on October 1, 2016. This contract is not set aside and is part of Sofie's broader portfolio of federal contracts and indefinite delivery vehicles (IDVs) to supply specialized radiopharmaceuticals, including PET imaging agents and...
- This is a federal contract award from the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The $204,375.00 firm-fixed-price purchase order is for the supply of radiopharmaceutical products. The contract does not have a set-aside designation. Sofie CO. is a specialized provider of molecular diagnostics and therapeutics, including radiopharmaceuticals, pharmaceuticals, and related services to various federal agencies such as the VA, Defense Health Agency...
- This is a federal contract award to Sofie CO., doing business as Sofie, for the provision of PET radiopharmaceuticals to the Department of Veterans Affairs (VA). The contract, valued at $77,670.00, is a firm fixed-price purchase order with a completion date of September 30, 2018. Sofie is a subsidiary of Sofie Biosciences, Inc. and specializes in the development and delivery of molecular diagnostics and therapeutics, particularly PET imaging agents and cancer treatment products. The contract...
- This $287,885.00 firm fixed-price purchase order contract was awarded by the Department of Veterans Affairs (VA) to Sofie CO., doing business as IBA Molecular, for the delivery of the F-18 Florbetaben (NeuraCeq) radiopharmaceutical product. NeuraCeq is a radioactive diagnostic agent used for Positron Emission Tomography (PET) imaging to estimate amyloid neuritic plaque density in patients with cognitive impairment being evaluated for Alzheimer's Disease. The contract has an ultimate completion...
- This federal contract award, valued at $282,073.55, was issued by the Department of Veterans Affairs (VA) to Sofie CO., a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of radiopharmaceuticals, which are specialized imaging agents used in medical diagnostics and cancer treatment. The contract is a firm fixed-price purchase order and has a set-aside designation for small businesses. Sofie CO. is an experienced provider of radiopharmaceuticals, pharmaceuticals, and related...
This is a firm-fixed-price purchase order awarded by the Department of Veterans Affairs (VA) Greater Los Angeles Healthcare System to Sofie CO., doing business as Sofie, a subsidiary of Sofie Biosciences, Inc. The contract is for the supply of 10 units of the radiopharmaceutical NEURACEQ at 8.1 mCi per dose, with a total ceiling value of $16,770.00. The period of performance is from December 1, 2023 through November 30, 2024. This award is not set aside and supports the VA's medical imaging and cancer treatment programs for veterans across the Greater Los Angeles region. Sofie Biosciences, Inc. is a specialized manufacturer and supplier of radiopharmaceuticals, pharmaceuticals, and related services to various federal agencies, including the VA, Defense Health Agency (DHA), and National Institutes of Health (NIH).
Name | Description | Solicitation Number | FederalAgency | Type | PostedDate |
|---|---|---|---|---|---|
6505--Neuraceq | 36C26224Q0223 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 | Solicitation 1/2 | 11/13/23, 4:15 PM | |
6505--Neuraceq | 36C26224Q0223 | Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22 | Award Notice 2/2 | 12/8/23, 1:16 PM |
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| P00001 | Supplemental Agreement for work within scope | $795 | 1/6/25 | |
| Not listed | Not listed | $16.0k | 12/4/23 |